Upregulated miR-106a plays an oncogenic role in pancreatic cancer

FEBS Letters

Volumn 588, Issue 5, 2014, Pages 705-712

  Li, Pei ^a   Xu, Qinhong ^a   Zhang, Dong ^a   Li, Xuqi ^a   Han, Liang ^a   Lei, Jianjun ^a   Duan, Wanxing ^a   Ma, Qingyong ^a   Wu, Zheng ^a   Wang, Zheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cell invasion; miR 106a; miRNA; Pancreatic cancer; Tissue inhibitors of metalloproteinase 2

Indexed keywords

MICRORNA; MICRORNA 106A; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

CELL INVASION; MIR-106A; MIRNA; PANCREATIC CANCER; TISSUE INHIBITORS OF METALLOPROTEINASE 2;

BASE SEQUENCE; BINDING SITES; CELL ADHESION MOLECULES; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELL SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICRORNAS; NEOPLASM INVASIVENESS; ONCOGENES; PANCREATIC NEOPLASMS; RNA INTERFERENCE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UP-REGULATION;

EID: 84896730351     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.01.007     Document Type: Article

References (33)

1. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
2. M.Z. Michael, S.M. O' Connor, N.G. van Holst Pellekaan, G.P. Young, and R.J. James Reduced accumulation of specific microRNAs in colorectal neoplasia Mol. Cancer Res. 1 2003 882 891
3. G.A. Calin, C.G. Liu, C. Sevignani, M. Ferracin, N. Felli, C.D. Dumitru, M. Shimizu, A. Cimmino, S. Zupo, M. Dono, M.L. Dell'Aquila, H. Alder, L. Rassenti, T.J. Kipps, F. Bullrich, M. Negrini, and C.M. Croce MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Proc. Natl. Acad. Sci. U S A 101 2004 11755 11760
4. J. Takamizawa, H. Konishi, K. Yanagisawa, S. Tomida, H. Osada, H. Endoh, T. Harano, Y. Yatabe, M. Nagino, Y. Nimura, T. Mitsudomi, and T. Takahashi Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res. 64 2004 3753 3756
5. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, and T.R. Golub MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
6. C. Zhang, J. Zhang, J. Hao, Z. Shi, Y. Wang, L. Han, S. Yu, Y. You, T. Jiang, J. Wang, M. Liu, P. Pu, and C. Kang High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma J. Transl. Med. 10 2012 119
7. S.K. Srivastava, A. Bhardwaj, S. Singh, S. Arora, B. Wang, W.E. Grizzle, and A.P. Singh MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells Carcinogenesis 32 2011 1832 1839
8. Y. Jiang, Y. Wu, A.R. Greenlee, J. Wu, Z. Han, X. Li, and Y. Zhao MiR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide Toxicol. Sci. 119 2011 50 60
9. S. Ali, A. Ahmad, S. Banerjee, S. Padhye, K. Dominiak, J.M. Schaffert, Z. Wang, P.A. Philip, and F.H. Sarkar Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF Cancer Res. 70 2010 3606 3617
10. F. Wang, X. Xue, J. Wei, Y. An, J. Yao, H. Cai, J. Wu, C. Dai, Z. Qian, Z. Xu, and Y. Miao Hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations Br. J. Cancer 103 2010 567 574
11. L. Cui, X. Zhang, G. Ye, T. Zheng, H. Song, H. Deng, B. Xiao, T. Xia, X. Yu, Y. Le, and J. Guo Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer Cancer 119 2013 1618 1626
12. T. Catela Ivkovic, G. Aralica, T. Cacev, B. Loncar, and S. Kapitanovic miR-106a overexpression and pRB downregulation in sporadic colorectal cancer Exp. Mol. Pathol. 94 2013 148 154
13. Z. Wang, M. Liu, H. Zhu, W. Zhang, S. He, C. Hu, L. Quan, J. Bai, and N. Xu MiR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS Mol. Carcinog. 52 2013 634 646
14. M. Tsujiura, D. Ichikawa, S. Komatsu, A. Shiozaki, H. Takeshita, T. Kosuga, H. Konishi, R. Morimura, K. Deguchi, H. Fujiwara, K. Okamoto, and E. Otsuji Circulating microRNAs in plasma of patients with gastric cancers Br. J. Cancer 102 2010 1174 1179
15. A.J. Schetter, S.Y. Leung, J.J. Sohn, K.A. Zanetti, E.D. Bowman, N. Yanaihara, S.T. Yuen, T.L. Chan, D.L. Kwong, G.K. Au, C.G. Liu, G.A. Calin, C.M. Croce, and C.C. Harris MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 2008 425 436
16. A. Link, F. Balaguer, Y. Shen, T. Nagasaka, J.J. Lozano, C.R. Boland, and A. Goel Fecal MicroRNAs as novel biomarkers for colon cancer screening Cancer Epidemiol. Biomarkers Prev. 19 2010 1766 1774
17. G. Yang, R. Zhang, X. Chen, Y. Mu, J. Ai, C. Shi, Y. Liu, C. Shi, L. Sun, N.G. Rainov, H. Li, B. Yang, and S. Zhao MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status J. Mol. Med. (Berlin) 89 2011 1037 1050
18. C. Chen, D.A. Ridzon, A.J. Broomer, Z. Zhou, D.H. Lee, J.T. Nguyen, M. Barbisin, N.L. Xu, V.R. Mahuvakar, M.R. Andersen, K.Q. Lao, K.J. Livak, and K.J. Guegler Real-time quantification of microRNAs by stem-loop RT-PCR Nucleic Acids Res. 33 2005 e179
19. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, and C.M. Croce A microRNA expression signature of human solid tumors defines cancer gene targets Proc. Natl. Acad. Sci. U S A 103 2006 2257 2261
20. F. Zhi, X. Chen, S. Wang, X. Xia, Y. Shi, W. Guan, N. Shao, H. Qu, C. Yang, Y. Zhang, Q. Wang, R. Wang, K. Zen, C.Y. Zhang, J. Zhang, and Y. Yang The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma Eur. J. Cancer 46 2010 1640 1649
21. M. Malumbres, and M. Barbacid To cycle or not to cycle: a critical decision in cancer Nat. Rev. Cancer 1 2001 222 231
22. S.H. Friend, R. Bernards, S. Rogelj, R.A. Weinberg, J.M. Rapaport, D.M. Albert, and T.P. Dryja A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma Nature 323 1986 643 646
23. D.L. Burkhart, and J. Sage Cellular mechanisms of tumour suppression by the retinoblastoma gene Nat. Rev. Cancer 8 2008 671 682
24. P. Indovina, E. Marcelli, N. Casini, V. Rizzo, and A. Giordano Emerging roles of RB family: new defense mechanisms against tumor progression J. Cell Physiol. 228 2013 525 535
25. B. Feng, T.T. Dong, L.L. Wang, H.M. Zhou, H.C. Zhao, F. Dong, and M.H. Zheng Colorectal cancer migration and invasion initiated by microRNA-106a PLoS One 7 2012 e43452
26. A. Rogers, M.J. Smith, P. Doolan, C. Clarke, M. Clynes, J.F. Murphy, A. McDermott, N. Swan, P. Crotty, P.F. Ridgway, and K.C. Conlon Invasive markers identified by gene expression profiling in pancreatic cancer Pancreatology 12 2012 130 140
27. J. Liu, Q.W. Ben, W.Y. Yao, J.J. Zhang, D.F. Chen, X.Y. He, L. Li, and Y.Z. Yuan BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK Front. Biosci. 17 2012 2541 2549
28. M. Durlik, and K. Gardian Metalloproteinase 2 and 9 activity in the development of pancreatic cancer Pol. Przegl. Chir. 84 2012 377 382
29. K. Kessenbrock, V. Plaks, and Z. Werb Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141 2010 52 67
30. Y.L. Gong, G.M. Xu, W.D. Huang, and L.B. Chen Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer J. Surg. Oncol. 73 2000 95 99
31. Y. Chen, Y. Xiao, W. Ge, K. Zhou, J. Wen, W. Yan, Y. Wang, B. Wang, C. Qu, J. Wu, L. Xu, and W. Cai MiR-200b inhibits TGF-beta1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells Cell Death Dis. 4 2013 e541
32. E.L. Paterson, J. Kazenwadel, A.G. Bert, Y. Khew-Goodall, A. Ruszkiewicz, and G.J. Goodall Down-regulation of the miRNA-200 family at the invasive front of colorectal cancers with degraded basement membrane indicates EMT is involved in cancer progression Neoplasia 15 2013 180 191
33. G. Martello, A. Rosato, F. Ferrari, A. Manfrin, M. Cordenonsi, S. Dupont, E. Enzo, V. Guzzardo, M. Rondina, T. Spruce, A.R. Parenti, M.G. Daidone, S. Bicciato, and S. Piccolo A MicroRNA targeting dicer for metastasis control Cell 141 2010 1195 1207